2011 Fiscal Year Final Research Report
Physiological situation based prediction of the adverse effects associated with molecularly-targeted drugs.
| Project/Area Number |
21390041
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
SUZUKI Hiroshi 東京大学, 医学部附属病院, 教授 (80206523)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
HISAKA Akihiro 東京大学, 医学部附属病院, 准教授 (80420206)
HONMA Masashi 東京大学, 医学部附属病院, 助教 (60401072)
MIURA Shougo 東京大学, 医学部附属病院, 助教 (90529182)
MIYAGAWA Kiyoshi 東京大学, 医学系研究科, 教授 (40200133)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | 癌 / 薬剤反応性 / キナーゼ / 分子標的薬 / オフ・ターゲット / 薬理学 / 薬物動態 |
|---|
| Research Abstract |
Various adverse effects associated with tyrosine kinase inhibitors, erlotinib or sunitinib, has been elucidated to link to the inhibition of off-target kinases, STK10 or PHKG1/2. Inhibition rate of off-target kinases under clinical concentration is potentially critical to predict the development of adverse effect.
|
